- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.01. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 09.01. | VITURA HEALTH LIMITED: Appointment of Chief Financial Officer | 3 | ASX | ||
| 05.01. | VITURA HEALTH LIMITED: Amended Constitution - Late Lodgement | - | ASX | ||
| 05.01. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 23.12.25 | VITURA HEALTH LIMITED: Change of Director's Interest Notice - Late Lodgement | 1 | ASX | ||
| 17.12.25 | VITURA HEALTH LIMITED: Change of Company Secretary | - | ASX | ||
| 01.12.25 | VITURA HEALTH LIMITED: Industry Advisory Group Charter | 2 | ASX | ||
| 26.11.25 | VITURA HEALTH LIMITED: Results of 2025 Annual General Meeting | 1 | ASX | ||
| 25.11.25 | VITURA HEALTH LIMITED: 2025 AGM presentation | - | ASX | ||
| 25.11.25 | VITURA HEALTH LIMITED: Withdrawal of resolution | 1 | ASX | ||
| 28.10.25 | VITURA HEALTH LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 27.10.25 | VITURA HEALTH LIMITED: Resignation of CFO and Company Secretary | 2 | ASX | ||
| 22.10.25 | VITURA HEALTH LIMITED: Notice of 2025 Annual General Meeting | - | ASX | ||
| 22.10.25 | VITURA HEALTH LIMITED: 2025 Annual Report | - | ASX | ||
| 01.10.25 | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | 1 | ASX | ||
| 25.09.25 | VITURA HEALTH LIMITED: Update - Dividend/Distribution - VIT | - | ASX | ||
| 25.09.25 | VITURA HEALTH LIMITED: DRP allocation price | - | ASX | ||
| 24.09.25 | VITURA HEALTH LIMITED: Date for 2025 AGM | - | ASX | ||
| 09.09.25 | VITURA HEALTH LIMITED: Becoming a substantial holder | - | ASX | ||
| 09.09.25 | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,615 | -0,96 % | Aurora Cannabis Inc (3): Aurora Cannabis to release Q3 results, host call Feb. 4 | ||
| TILRAY BRANDS | 7,350 | 0,00 % | Tilray, Canopy & Co. zittern: Cannabis-Aktien 2026: Neuer Boom oder Crash? Was Anleger jetzt wissen müssen | © Foto: adobe.stock.comWird 2026 für Cannabis-Aktien ein weiteres Seuchenjahr oder das Jahr der Wiederauferstehung? Die Erwartungen hinsichtlich einer Trendwende sind hoch, doch beide Szenarien sind... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,330 | -1,48 % | Organigram Global Inc: Organigram increases Phylos loan by $3-million (U.S.) | ||
| SNDL | 1,318 | -1,86 % | SNDL Inc. (SNDL) Completes Initial 1CM Retail Acquisition, Expands Footprint Across Western Canada | ||
| MYDECINE INNOVATIONS GROUP | 0,125 | -0,80 % | XFRA NEW INSTRUMENTS AVAILABLE ON 22.10.2025 | The following instruments on XETRA do have their first trading 22.10.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 22.10.2025
Aktien
1 KYG8827C1006 Malibu Life Holdings... ► Artikel lesen | |
| BIONANO GENOMICS | 1,530 | 0,00 % | Bionano Genomics: Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress | SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. "Over the last year, we have taken... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 14,900 | -1,32 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800) | Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study Expect to have investigational product of TNX-4800 (anti-Borrelia... ► Artikel lesen | |
| HIGH TIDE | 2,105 | -0,94 % | High Tide Inc. (HITI): Among High Growth Canadian Stocks to Buy | ||
| ACHIEVE LIFE SCIENCES | 4,205 | -1,87 % | Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer | SEATTLE and VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development... ► Artikel lesen | |
| JAGUAR HEALTH | 0,741 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi | Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for Mytesi and Canalevia-CA1, which has the potential to provide Jaguar up to an additional... ► Artikel lesen | |
| MEDIPHARM LABS | 0,047 | +4,48 % | Medipharm Labs Corp: Medipharm Labs' Pidduck resigns as CEO | ||
| ARGENT BIOPHARMA | 0,026 | -5,56 % | Argent BioPharma Ltd.: Argent is Growing Through M&A: Projected Merged Company Value of $100M in AC8 Asset Acquisition | Acquisition Expands Clinical Pipeline, Strengthens IP Portfolio, and Grows EU Presence
Highlights
Binding term sheet signed to acquire key assets and IP of AusCann... ► Artikel lesen | |
| AUSCANN | - | - | Argent BioPharma Signs $15m Deal to Acquire Key Clinical and IP Assets from AusCann | ||
| AYR WELLNESS | 0,040 | 0,00 % | Ayr Wellness Inc. - 6-K, Report of foreign issuer |
VITURA HEALTH LIMITED gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -1,79 % bei einem Aktienkurs von 0,028 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.